v3.25.4

Segment Information | 6 Months Ended
--- | ---
Dec. 31, 2025
Segment Reporting [Abstract] |
Segment Information | SEGMENT INFORMATION As of July 1, 2024, the Company realigned its reportable segments for fiscal year 2025. The Auto & Home business does not meet the quantitative thresholds to be required to continue to be separately disclosed as a reportable segment in accordance with ASC 280, Segment Reporting (“ASC 280”). As a result, the Auto & Home business will be included in an “All Other” category. Prior period information has been recast to conform to the current presentation. The Company’s operating segments and reportable segments have been determined in accordance with ASC 280. We currently have three reportable segments: i) Senior, ii) Healthcare Services, and iii) Life. Senior primarily sells senior Medicare-related health insurance products. Healthcare Services includes SelectRx, Healthcare Select, and SPM. Healthcare Services provides products and services to our Medicare policyholders, which are focused on improving patient health outcomes. Life primarily sells term life and final expense products. The All Other category is reflective of the revenue generated from selling individual automobile and homeowners’ insurance. Additionally, the Company accounts for non-operating activity, share-based compensation expense, depreciation and amortization, goodwill, impairment charges, certain intersegment eliminations, and the costs of providing corporate and other administrative services in our administrative division, Corporate & Eliminations. Our operating segments are determined based on how our chief executive officer, who also serves as our chief operating decision maker (“CODM”), manages our business, regularly accesses information, and evaluates performance for operating decision-making purposes, including allocation of resources. Adjusted EBITDA is our segment profit measure and a key measure used by our CODM and Board of Directors to understand and evaluate the operating performance of our business and on which internal budgets and forecasts are based and approved. Our segment disclosure includes intersegment revenues, which consist of affiliate marketing fees for services provided by our Senior segment to our Healthcare Services and Life segments as well as services provided by Life to other segments. These intersegment transactions are recorded by each segment at amounts that we believe approximate fair value as if the transactions were between third parties and, therefore, impact segment performance. However, the revenue and corresponding expense are eliminated in consolidation. The elimination of such intersegment transactions is included within the “Eliminations of intersegment revenues” in the tables below. Apart from these intersegment transactions, the accounting policies of the reportable segments are the same as the Company’s described Note 1 to the condensed consolidated financial statements. The following tables present information about the reportable segments for the periods presented. We do not report total assets by segment as our CODM does not use this information to evaluate operating segment performance. Accordingly, we do not regularly provide such information by segment to our CODM. Three Months Ended December 31, 2025:
(in thousands) | Senior |  | Healthcare Services |  | Life |  |  |  |  |  | Total
External revenue | $ | 259,201 |  |  | $ | 230,412 |  |  | $ | 43,598 |  |  |  |  |  |  | $ | 533,211 |
Intersegment revenue | 2,338 |  |  | 242 |  |  | 25 |  |  |  |  |  |  | 2,605 |
Total revenue from reportable segments | $ | 261,539 |  |  | $ | 230,654 |  |  | $ | 43,623 |  |  |  |  |  |  | $ | 535,816 |
All other revenue (1) |  |  |  |  |  |  |  |  |  |  | 3,891 |
Eliminations of intersegment revenues |  |  |  |  |  |  |  |  |  |  | (2,605) |
Total consolidated revenue |  |  |  |  |  |  |  |  |  |  | $ | 537,102 |
(1) Represents revenue from SQAH, a non-reportable segment.
(in thousands) | Senior |  | Healthcare Services |  | Life |  |  |  | Total
Total revenue from reportable segments | $ | 261,539 |  |  | $ | 230,654 |  |  | $ | 43,623 |  |  |  |  | $ | 535,816 |
Less: |  |  |  |  |  |  |  |  |
Cost of commissions and other services revenue | (74,391) |  |  | (8,357) |  |  | (17,404) |  |  |  |  |
Cost of goods sold - pharmacy revenue | — |  |  | (203,783) |  |  | — |  |  |  |  |
Marketing expense (1) | (84,056) |  |  | (2,235) |  |  | (20,376) |  |  |  |  |
Technical development (2) | — |  |  | (311) |  |  | — |  |  |  |  |
Selling, general, and administrative (3) | (640) |  |  | (15,122) |  |  | (262) |  |  |  |  |
Adjusted Segment EBITDA | $ | 102,452 |  |  | $ | 846 |  |  | $ | 5,581 |  |  |  |  | $ | 108,879 |
Reconciliation of total segment Adjusted EBITDA |  |  |  |  |  |  |  |  |
All other Adjusted EBITDA (4) |  |  |  |  |  |  |  |  | 2,102 |
Corporate (5) |  |  |  |  |  |  |  |  | (26,250) |
Share-based compensation expense |  |  |  |  |  |  |  |  | (3,475) |
Transaction costs (6) |  |  |  |  |  |  |  |  | (662) |
Depreciation and amortization |  |  |  |  |  |  |  |  | (4,322) |
Impairment of equity-method investment (7) |  |  |  |  |  |  |  |  | (1,000) |
Change in fair value of warrants |  |  |  |  |  |  |  |  | 19,296 |
Interest expense, net |  |  |  |  |  |  |  |  | (11,613) |
Income before income tax expense (benefit) |  |  |  |  |  |  |  |  | $ | 82,955 |
(1) Primarily consists of direct advertising and lead generation costs across various marketing channels. (2) Primarily comprised of payroll and related benefits for dedicated Healthcare Services IT personnel. (3) For Senior and Life, these costs are primarily comprised of allocations from corporate related to payroll and related benefits for administrative support functions and facilities. Within Healthcare Services, it primarily consists of payroll and related benefit costs for licensed pharmacists and pharmacy technicians performing one-time customer onboarding work for enrollments that don’t actually become members. (4) Represents adjusted EBITDA from SQAH, a non-reportable segment. (5) Corporate is not an operating segment and consists primarily of unallocated corporate overhead costs, such as payroll and related benefits ($17.4 million), professional services ($5.0 million), and facilities ($1.4 million). (6) These expenses primarily consist of financing transaction costs ($0.3 million) and non-restructuring severance expenses ($0.3 million). (7) During the three months ended December 31, 2025, the Company recognized an impairment charge of $1.0 million representing a full write-off of its equity-method investment. Three Months Ended December 31, 2024:
(in thousands) | Senior |  | Healthcare Services |  | Life |  |  |  |  |  | Total
External revenue | $ | 253,805 |  |  | $ | 183,281 |  |  | $ | 39,840 |  |  |  |  |  |  | $ | 476,926 |
Intersegment revenue | 1,773 |  |  | 89 |  |  | 21 |  |  |  |  |  |  | 1,883 |
Total revenue from reportable segments | $ | 255,578 |  |  | $ | 183,370 |  |  | $ | 39,861 |  |  |  |  |  |  | $ | 478,809 |
All other revenue (1) |  |  |  |  |  |  |  |  |  |  | 4,143 |
Eliminations of intersegment revenues |  |  |  |  |  |  |  |  |  |  | (1,883) |
Total consolidated revenue |  |  |  |  |  |  |  |  |  |  | $ | 481,069 |
(1) Represents revenue from SQAH, a non-reportable segment.
(in thousands) | Senior |  | Healthcare Services |  | Life |  |  |  | Total
Total revenue from reportable segments | $ | 255,578 |  |  | $ | 183,370 |  |  | $ | 39,861 |  |  |  |  | $ | 478,809 |
Less: |  |  |  |  |  |  |  |  |
Cost of commissions and other services revenue | (75,042) |  |  | (7,932) |  |  | (15,041) |  |  |  |  |
Cost of goods sold - pharmacy revenue | — |  |  | (155,009) |  |  | — |  |  |  |  |
Marketing expense (1) | (79,398) |  |  | (1,902) |  |  | (17,172) |  |  |  |  |
Technical development (2) | — |  |  | (592) |  |  | — |  |  |  |  |
Selling, general, and administrative (3) | (617) |  |  | (15,723) |  |  | (225) |  |  |  |  |
Adjusted Segment EBITDA | $ | 100,521 |  |  | $ | 2,212 |  |  | $ | 7,423 |  |  |  |  | $ | 110,156 |
Reconciliation of total segment Adjusted EBITDA |  |  |  |  |  |  |  |  |
All other Adjusted EBITDA (4) |  |  |  |  |  |  |  |  | 2,303 |
Corporate (5) |  |  |  |  |  |  |  |  | (24,940) |
Share-based compensation expense |  |  |  |  |  |  |  |  | (4,699) |
Transaction costs (6) |  |  |  |  |  |  |  |  | (6,719) |
Depreciation and amortization |  |  |  |  |  |  |  |  | (5,060) |
Loss on disposal of property, equipment, and software, net |  |  |  |  |  |  |  |  | (122) |
Change in fair value of warrants |  |  |  |  |  |  |  |  | (7,642) |
Interest expense, net |  |  |  |  |  |  |  |  | (23,721) |
Income before income tax expense (benefit) |  |  |  |  |  |  |  |  | $ | 39,556 |
(1) Primarily consists of direct advertising and lead generation costs across various marketing channels. (2) Primarily comprised of payroll and related benefits for dedicated Healthcare Services IT personnel. (3) For Senior and Life, these costs are primarily comprised of allocations from corporate related to payroll and related benefits for administrative support functions and facilities. Within Healthcare Services, it primarily consists of payroll and related benefit costs for licensed pharmacists and pharmacy technicians performing one-time customer onboarding work for enrollments that don’t actually become members. (4) Represents adjusted EBITDA from SQAH, a non-reportable segment. (5) Corporate is not an operating segment and consists primarily of unallocated corporate overhead costs, such as payroll and related benefits ($17.3 million), professional services ($4.0 million), and facilities ($1.3 million). (6) These expenses primarily consist of financing transaction costs ($6.7 million). Six Months Ended December 31, 2025:
(in thousands) | Senior |  | Healthcare Services |  | Life |  |  |  |  |  | Total
External revenue | $ | 316,499 |  |  | $ | 451,650 |  |  | $ | 90,226 |  |  |  |  |  |  | $ | 858,375 |
Intersegment revenue | 4,037 |  |  | 355 |  |  | 43 |  |  |  |  |  |  | 4,435 |
Total revenue from reportable segments | $ | 320,536 |  |  | $ | 452,005 |  |  | $ | 90,269 |  |  |  |  |  |  | $ | 862,810 |
All other revenue (1) |  |  |  |  |  |  |  |  |  |  | 7,538 |
Eliminations of intersegment revenues |  |  |  |  |  |  |  |  |  |  | (4,435) |
Total consolidated revenue |  |  |  |  |  |  |  |  |  |  | $ | 865,913 |
(1) Represents revenue from SQAH, a non-reportable segment.
(in thousands) | Senior |  | Healthcare Services |  | Life |  |  |  | Total
Total revenue from reportable segments | $ | 320,536 |  |  | $ | 452,005 |  |  | $ | 90,269 |  |  |  |  | $ | 862,810 |
Less: |  |  |  |  |  |  |  |  |
Cost of commissions and other services revenue | (116,288) |  |  | (14,658) |  |  | (35,382) |  |  |  |  |
Cost of goods sold - pharmacy revenue | — |  |  | (395,181) |  |  | — |  |  |  |  |
Marketing expense (1) | (121,686) |  |  | (4,623) |  |  | (43,136) |  |  |  |  |
Technical development (2) | — |  |  | (749) |  |  | — |  |  |  |  |
Selling, general, and administrative (3) | (1,147) |  |  | (28,736) |  |  | (599) |  |  |  |  |
Adjusted Segment EBITDA | $ | 81,415 |  |  | $ | 8,058 |  |  | $ | 11,152 |  |  |  |  | $ | 100,625 |
Reconciliation of total segment Adjusted EBITDA |  |  |  |  |  |  |  |  |
All other Adjusted EBITDA (4) |  |  |  |  |  |  |  |  | 3,989 |
Corporate (5) |  |  |  |  |  |  |  |  | (51,962) |
Share-based compensation expense |  |  |  |  |  |  |  |  | (7,802) |
Transaction costs (6) |  |  |  |  |  |  |  |  | (846) |
Depreciation and amortization |  |  |  |  |  |  |  |  | (8,622) |
Impairment of equity-method investment (7) |  |  |  |  |  |  |  |  | (1,000) |
Change in fair value of warrants |  |  |  |  |  |  |  |  | 34,332 |
Interest expense, net |  |  |  |  |  |  |  |  | (23,421) |
Income before income tax expense (benefit) |  |  |  |  |  |  |  |  | $ | 45,293 |
(1) Primarily consists of direct advertising and lead generation costs across various marketing channels. (2) Primarily comprised of payroll and related benefits for dedicated Healthcare Services IT personnel. (3) For Senior and Life, these costs are primarily comprised of allocations from corporate related to payroll and related benefits for administrative support functions and facilities. Within Healthcare Services, it primarily consists of payroll and related benefit costs for licensed pharmacists and pharmacy technicians performing one-time customer onboarding work for enrollments that don’t actually become members. (4) Represents adjusted EBITDA from SQAH, a non-reportable segment. (5) Corporate is not an operating segment and consists primarily of unallocated corporate overhead costs, such as payroll and related benefits ($35.2 million), professional services ($9.1 million), and facilities ($2.7 million). (6) These expenses primarily consist of financing transaction costs ($0.5 million) and non-restructuring severance expenses ($0.4 million). (7) During the six months ended December 31, 2025, the Company recognized an impairment charge of $1.0 million representing a full write-off of its equity-method investment. Six Months Ended December 31, 2024:
(in thousands) | Senior |  | Healthcare Services |  | Life |  |  |  |  |  | Total
External revenue | $ | 345,169 |  |  | $ | 338,947 |  |  | $ | 79,106 |  |  |  |  |  |  | $ | 763,222 |
Intersegment revenue | 3,318 |  |  | 161 |  |  | 45 |  |  |  |  |  |  | 3,524 |
Total revenue from reportable segments | $ | 348,487 |  |  | $ | 339,108 |  |  | $ | 79,151 |  |  |  |  |  |  | $ | 766,746 |
All other revenue (1) |  |  |  |  |  |  |  |  |  |  | 10,110 |
Eliminations of intersegment revenues |  |  |  |  |  |  |  |  |  |  | (3,524) |
Total consolidated revenue |  |  |  |  |  |  |  |  |  |  | $ | 773,332 |
(1) Represents revenue from SQAH, a non-reportable segment.
(in thousands) | Senior |  | Healthcare Services |  | Life |  |  |  | Total
Total revenue from reportable segments | $ | 348,487 |  |  | $ | 339,108 |  |  | $ | 79,151 |  |  |  |  | $ | 766,746 |
Less: |  |  |  |  |  |  |  |  |
Cost of commissions and other services revenue | (116,169) |  |  | (13,812) |  |  | (29,613) |  |  |  |  |
Cost of goods sold - pharmacy revenue | — |  |  | (283,375) |  |  | — |  |  |  |  |
Marketing expense (1) | (122,775) |  |  | (4,149) |  |  | (35,667) |  |  |  |  |
Technical development (2) | — |  |  | (1,200) |  |  | — |  |  |  |  |
Selling, general, and administrative (3) | (1,296) |  |  | (29,483) |  |  | (488) |  |  |  |  |
Adjusted Segment EBITDA | $ | 108,247 |  |  | $ | 7,089 |  |  | $ | 13,383 |  |  |  |  | $ | 128,719 |
Reconciliation of total segment Adjusted EBITDA |  |  |  |  |  |  |  |  |
All other Adjusted EBITDA (4) |  |  |  |  |  |  |  |  | 6,099 |
Corporate (5) |  |  |  |  |  |  |  |  | (48,983) |
Share-based compensation expense |  |  |  |  |  |  |  |  | (8,545) |
Transaction costs (6) |  |  |  |  |  |  |  |  | (7,544) |
Depreciation and amortization |  |  |  |  |  |  |  |  | (10,659) |
Loss on disposal of property, equipment, and software, net |  |  |  |  |  |  |  |  | (157) |
Change in fair value of warrants |  |  |  |  |  |  |  |  | (7,642) |
Interest expense, net |  |  |  |  |  |  |  |  | (46,752) |
Income before income tax expense (benefit) |  |  |  |  |  |  |  |  | $ | 4,536 |
(1) Primarily consists of direct advertising and lead generation costs across various marketing channels. (2) Primarily comprised of payroll and related benefits for dedicated Healthcare Services IT personnel. (3) For Senior and Life, these costs are primarily comprised of allocations from corporate related to payroll and related benefits for administrative support functions and facilities. Within Healthcare Services, it primarily consists of payroll and related benefit costs for licensed pharmacists and pharmacy technicians performing one-time customer onboarding work for enrollments that don’t actually become members. (4) Represents adjusted EBITDA from SQAH, a non-reportable segment. (5) Corporate is not an operating segment and consists primarily of unallocated corporate overhead costs, such as payroll and related benefits ($32.8 million), professional services ($8.8 million), and facilities ($2.8 million). (6) These expenses primarily consist of non-restructuring severance expenses ($0.5 million) and financing transaction costs ($7.0 million). Revenues from each of the reportable segments are earned from transactions in the United States and follow the same accounting policies used for the Company’s condensed consolidated financial statements. All of the Company’s long-lived assets are located in the United States. For the three months ended December 31, 2025, three insurance carrier customers accounted for 37% (UHC), 19% (Humana), and 13% (Aetna), of total revenue. For the three months ended December 31, 2024, three insurance carrier customers accounted for 38% (UHC), 14% (Humana), and 16% (Aetna) of total revenue. For the six months ended December 31, 2025, three insurance carrier customers accounted for 40% (UHC), 14% (Humana) and 12% (Aetna), of total revenue. For the six months ended December 31, 2024, three customers accounted for 35% (UHC), 13% (Humana), and 17% (Aetna) of total revenue. For all periods presented, the revenue was provided by both the Senior and Healthcare Services segments.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 12: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 13: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 14: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 15: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 16: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 17: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/280/tableOfContent Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration